Lumida
/OFLX
⌘K
Omega Flex Inc

Omega Flex Inc

OFLX
$25.58USD+0.27%+0.07 today

MARKET CAP

258.2M

P/E (TTM)

19.2x

FWD P/E

DAY RANGE

$25 – $26

52W RANGE

$25
$38

AI Summary

Stalk
TrimMedium

The stock remains in a Stage 4 decline following a decisive support failure, confirming a dominant downtrend with lower highs and lower lows. Recent relief rallies have been sold into dynamic resistance, and price is currently rebounding but well below the declining 9 and 21 EMAs without signs of exhaustion. Short-term conditions remain indeterminate until price reaches the sloping EMAs. Execution should be deferred and a trim into the dynamic resistance zone around the 9 and 21 EMA is recommended.

  • Q2 EPS $0.27, net margin 13.6% and ROE 15.9% highlight efficiency
  • CE Mark for MediTrac tubing may drive medical segment growth
  • Significant negative growth factor implies limited future expansion
Full analysis →
STATEMENT·Income statement
USD · GAAP
METRICFY 2021FY 2022FY 2023FY 2024FY 2025TREND
Sales, Adj.$130.0M$125.5M$111.5M$101.7M$98.3M
YoY %+22.9%-3.5%-11.2%-8.8%-3.3%
P / Sales9.9x7.4x6.4x4.2x3.0x
EV / Sales9.8x7.3x6.2x3.9x2.7x
Gross Profit, Adj.$81.5M$78.3M$68.4M$62.3M$59.0M
YoY %+22.5%-4.0%-12.7%-8.9%-5.2%
Margin %62.7%62.4%61.3%61.2%60.0%
EV / Gross Profit15.7x11.8x10.1x6.3x4.5x
EBITDA, Adj.$36.1M$32.1M$26.9M$22.8M$18.3M
YoY %+31.1%-11.0%-16.2%-15.1%-19.9%
Margin %27.8%25.6%24.1%22.4%18.6%
EV / EBITDA35.4x28.7x25.8x17.3x14.5x
EBIT$35.1M$31.0M$25.8M$21.6M$16.9M
YoY %+31.5%-11.5%-16.8%-16.4%-21.5%
Margin %27.0%24.7%23.1%21.2%17.2%
EV / EBIT36.4x29.7x26.9x18.3x15.6x
Net Income$26.2M$23.6M$20.8M$18.0M$14.8M
YoY %+31.6%-9.8%-12.1%-13.2%-17.7%
Net Margin20.1%18.8%18.6%17.7%15.1%
EPS (GAAP)$2.60$2.34$2.06$1.78$1.47
YoY %+32.0%-10.0%-12.0%-13.6%-17.4%